Standout Papers
Citation Impact
Citing Papers
Etanercept plus Standard Therapy for Wegener's Granulomatosis
2005
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Stroke in Infants and Children
2008
A New Triggering Receptor Expressed on Myeloid Cells (Trem) Family Member, Trem-Like 4, Binds to Dead Cells and Is a DNAX Activation Protein 12-Linked Marker for Subsets of Mouse Macrophages and Dendritic Cells
2009 StandoutNobel
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis
2005
Antimicrobial Lock Solutions for the Prevention of Infections Associated with Intravascular Catheters in Patients Undergoing Hemodialysis: Systematic Review and Meta‐analysis of Randomized, Controlled Trials
2008
Sensitivity of a Dutch Health Assessment Questionnaire in a Trial Comparing Hydroxychloroquine vs. Sulphasalazine
1990
Netting neutrophils in autoimmune small-vessel vasculitis
2009 Standout
Observational Study of Need for Thrombolytic Therapy and Incidence of Bacteremia using Taurolidine‐Citrate‐Heparin, Taurolidine‐Citrate and Heparin Catheter Locks in Patients Treated with Hemodialysis
2011
Acute kidney injury
2012 Standout
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement
2006
Guidelines for the Prevention of Intravascular Catheter-related Infections: Recommendations Relevant to Interventional Radiology for Venous Catheter Placement and Maintenance
2012
Efforts to Prevent and Halt Autoimmune Beta Cell Destruction
2010
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
2006
Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis
2004
Rheumatoid arthritis
2016 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Antineutrophil cytoplasmic antibodies
2006
Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials
2007
Locking Tunneled Hemodialysis Catheters with Hypertonic Saline (26% NaCl) and Heparin to Prevent Catheter-Related Bloodstream Infections and Thrombosis: A Randomized, Prospective Trial
2012
Prospective Study of TNFα Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis
2004
Sodium Citrate Versus Heparin Catheter Locks for Cuffed Central Venous Catheters: A Single-Center Randomized Controlled Trial
2009
Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients
2007
Current Management of Vascular Access
2007
Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients
2004
Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis
2014
Minocycline-EDTA Lock Solution Prevents Catheter-Related Bacteremia in Hemodialysis
2011
Apoptosis: controlled demolition at the cellular level
2007 Standout
Hemodialysis Catheter Design and Catheter Performance: A Randomized Controlled Trial
2014
Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis
2005
Approaches to Prolong the Use of Uncuffed Hemodialysis Catheters: Results of a Randomized Trial
2011
A Meta-analysis of Hemodialysis Catheter Locking Solutions in the Prevention of Catheter-Related Infection
2008
Validity and discriminant ability of the HAQ Functional Index in early rheumatoid arthritis
1992
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
2010
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides
2006
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
2005
Traditional and non-traditional strategies to optimize catheter function: go with more flow
2010
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
2007
ANCA-associated vasculitides—advances in pathogenesis and treatment
2010
IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.
1996
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Long-term Follow-up of the Hemodialysis Infection Prevention With Polysporin Ointment (HIPPO) Study: A Quality Improvement Report
2011
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis
2007
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody–associated vasculitis
2005
Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces
2006
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
2014
Plasma adiponectin concentration and left ventricular hypertrophy in kidney transplant patients
2010
Complement Deficiency and Autoimmunitya
1997
Prevention of Tunneled Cuffed Hemodialysis Catheter–Related Dysfunction and Bacteremia by a Neutral-Valve Closed-System Connector: A Single-Center Randomized Controlled Trial
2012
Epidemiology, Surveillance, and Prevention of Bloodstream Infections in Hemodialysis Patients
2010
Cerebral Sinovenous Thrombosis in Children
2001 Standout
The Development of a Hierarchical Polychotomous ADL-IADL Scale for Noninstitutionalized Elders
1990
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial
2007
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
2004
Type 1 diabetes
2013 Standout
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications
2001
Assessing Disability in Patients with Rheumatoid Arthritis
1988
Prevention and management of catheter-related infection in hemodialysis patients
2010
Catheter Management in Hemodialysis Patients
2010
Rheumatoid arthritis
2010 Standout
Interventional Nephrology
2013
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
ANCA Disease
2010
Complement
2001
Systemic Lupus Erythematosus
2008
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis
2009
Nine patients with anti‐neutrophil cytoplasmic antibody‐positive vasculitis successfully treated with rituximab
2005
EBPG on Vascular Access
2007
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Points of control in inflammation
2002 StandoutNature
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
2007
Comparative Effectiveness of Two Catheter Locking Solutions to Reduce Catheter-Related Bloodstream Infection in Hemodialysis Patients
2014
A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial*
2011
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 Standout
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
2011
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Comparison of Low-Dose Gentamicin With Minocycline as Catheter Lock Solutions in the Prevention of Catheter-Related Bacteremia
2006
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
2007
Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections
2011
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Successful Prevention of Cuffed Hemodialysis Catheter-Related Infection Using an Antibiotic Lock Technique by Strictly Catheter-Restricted Antibiotic Lock Solution Method
2009
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia
2009
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Adipose Tissue as an Endocrine Organ
2004 Standout
Complications of Catheters: Tunneled and Nontunneled
2012
Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]
2006
Emergence of Gentamicin-Resistant Bacteremia in Hemodialysis Patients Receiving Gentamicin Lock Catheter Prophylaxis
2010
Autoimmunity and interstitial lung disease
2005
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
2006 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double‐blind clinical trial
2006
Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures
2000 Standout
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Rituximab for Refractory Wegener's Granulomatosis
2005
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Functional Analysis of Recombinant Calreticulin Fragment 39–272: Implications for Immunobiological Activities of Calreticulin in Health and Disease
2010
Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution.
1989
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
2016
Hemodialysis Tunneled Catheter-Related Infections
2016
Prevention of Hemodialysis Catheter-Related Blood Stream Infections using a Cotrimoxazole-Lock Technique
2015
Bladder Cancer
2020 Standout
Review : Serological markers of disease activity in systemic lupus erythematosus
1995
Intravenous Immunoglobulin (IVIg) Therapy in MPO-ANCA Related Polyangiitis with Rapidly Progressive Glomerulonephritis in Japan
2004
Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.
1992
Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis.
1991
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Infection Associated with Tunneled Hemodialysis Catheters
2008
Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults
2014
Cerebral venous thrombosis
2004
C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells
2001
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
[The Rotterdam study].
2011
Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis
2018
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms.
1993
Works of C. E. H. Siegert being referenced
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients
2005
Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial
2009
IgG and IgA antibodies to the collagen‐like region of C1q in rheumatoid vasculitis
1990
Antithymocyte globulin treatment of orbital Wegener granulomatosis: a follow-up study
1999
The Relationship between Serum Titers of Autoantibodies to C1q and Age in the General Population and in Patients with Systemic Lupus Erythematosus
1993
Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 – 5 chronic kidney disease
2009
Antiendothelial Cell Antibodies in Systemic Lupus erythematosus: Enhanced Antibody Binding to lnterleukin-1-Stimulated Endothelium
1994
Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE)
1998
Autoantibodies against C1q: view on clinical relevance and pathogenic roles
1999
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)
1991
IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
1991
Elastase and collagenase activities in synovial fluid of patients with arthritis.
1987
Superior Sagittal Sinus Thrombosis and Thyrotoxicosis
1995
Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
1993
Measurement of disability in Dutch rheumatoid arthritis patients
1984